Raymond James analyst Aaron Kessler maintains CarGurus (NASDAQ:CARG) with a Outperform and raises the price target from $38 to $41.
T2 Biosystems Q4 EPS $(1.41) Beats $(1.70) Estimate, Sales $5.48M Beat $5.40M Estimate
T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(1.70) by 17.06 percent. This is a 59.71 percent increase over losses of $(3.50) per share from the
